Five Alarm Bio is a start-up company deploying breakthrough understanding about the nature of ageing to develop therapeutics for a wide range of diseases. The technical focus is on the chemical damage that accumulates with ageing, its effect on the body, and how that damage can be delayed or reversed.
The CEO of Five Alarm Bio will build on these initial results to help secure funding and to build a leading drug discovery company, targeting age-associated disease and disability. The goal is to lead the company to the point where it can conclude significant commercial deals with major pharma companies, providing the commercial validation of the technology. The critical first goal is closing a seed round of at least £0.5M.
This is a role for an ambitious, energetic, commercial individual who can build on their commercial reputation. Experience of a lean, virtual start-up environment is key. It is important that the individual can work effectively with the scientific founder and with other shareholders, third party financial advisors and City contacts. Experience in small molecule R&D would be valuable.